Pharmacotherapy for cluster headache
Autor: | Rolf Fronczek, Roemer B. Brandt, Joost Haan, Patty G. G. Doesborg, Michel D. Ferrari |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Topiramate
Pain Cluster Headache Triptans Review Article Pizotifen Dihydroergotamine 03 medical and health sciences 0302 clinical medicine medicine Humans Pharmacology (medical) business.industry Cluster headache medicine.disease 030227 psychiatry Psychiatry and Mental health Sumatriptan Pharmaceutical Preparations Anesthesia Verapamil Neurology (clinical) Frovatriptan business 030217 neurology & neurosurgery medicine.drug |
Zdroj: | CNS Drugs, 34(2), 171-184. ADIS INT LTD CNS Drugs |
Popis: | Cluster headache is characterised by attacks of excruciating unilateral headache or facial pain lasting 15 min to 3 h and is seen as one of the most intense forms of pain. Cluster headache attacks are accompanied by ipsilateral autonomic symptoms such as ptosis, miosis, redness or flushing of the face, nasal congestion, rhinorrhoea, peri-orbital swelling and/or restlessness or agitation. Cluster headache treatment entails fast-acting abortive treatment, transitional treatment and preventive treatment. The primary goal of prophylactic and transitional treatment is to achieve attack freedom, although this is not always possible. Subcutaneous sumatriptan and high-flow oxygen are the most proven abortive treatments for cluster headache attacks, but other treatment options such as intranasal triptans may be effective. Verapamil and lithium are the preventive drugs of first choice and the most widely used in first-line preventive treatment. Given its possible cardiac side effects, electrocardiogram (ECG) is recommended before treating with verapamil. Liver and kidney functioning should be evaluated before and during treatment with lithium. If verapamil and lithium are ineffective, contraindicated or discontinued because of side effects, the second choice is topiramate. If all these drugs fail, other options with lower levels of evidence are available (e.g. melatonin, clomiphene, dihydroergotamine, pizotifen). However, since the evidence level is low, we also recommend considering one of several neuromodulatory options in patients with refractory chronic cluster headache. A new addition to the preventive treatment options in episodic cluster headache is galcanezumab, although the long-term effects remain unknown. Since effective preventive treatment can take several weeks to titrate, transitional treatment can be of great importance in the treatment of cluster headache. At present, greater occipital nerve injection is the most proven transitional treatment. Other options are high-dose prednisone or frovatriptan. |
Databáze: | OpenAIRE |
Externí odkaz: |